Found: 287
Select item for more details and to access through your institution.
Clinically Relevant Characterization and Comparison of Ryaltris and Other Anti-Allergic Nasal Sprays.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 8, p. 989, doi. 10.3390/pharmaceutics16080989
- By:
- Publication type:
- Article
Evaluation of the ocular safety associated with the exhalation delivery system with fluticasone.
- Published in:
- Allergy & Asthma Proceedings, 2022, v. 43, n. 1, p. 70, doi. 10.2500/aap.2022.43.210096
- By:
- Publication type:
- Article
A generic fluticasone propionate and salmeterol dry powder inhaler: Evidence of usability, function, and robustness.
- Published in:
- Allergy & Asthma Proceedings, 2021, v. 42, n. 1, p. 30, doi. 10.2500/aap.2021.42.200112
- By:
- Publication type:
- Article
Deposition characteristics of a novel intranasal formulation of azelastine hydrochloride plus fluticasone propionate in an anatomic model of the human nasal cavity.
- Published in:
- Allergy & Asthma Proceedings, 2020, v. 41, n. 4, p. 265, doi. 10.2500/aap.2020.41.200028
- By:
- Publication type:
- Article
Adherence and usage patterns of inhaled corticosteroids- long-acting beta-agonists by using inhaler-monitoring technology.
- Published in:
- Allergy & Asthma Proceedings, 2020, v. 41, n. 4, p. 256, doi. 10.2500/aap.2020.41.200037
- By:
- Publication type:
- Article
Treatment with azelastine hydrochloride and fluticasone propionate in a single delivery device of young children and adolescents with allergic rhinitis.
- Published in:
- Allergy & Asthma Proceedings, 2020, v. 41, n. 4, p. 232, doi. 10.2500/aap.2020.41.200034
- By:
- Publication type:
- Article
Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial.
- Published in:
- Allergy & Asthma Proceedings, 2018, v. 39, n. 2, p. 110, doi. 10.2500/aap.2018.39.4116
- By:
- Publication type:
- Article
Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma.
- Published in:
- Allergy & Asthma Proceedings, 2017, v. 38, n. 5, p. 343, doi. 10.2500/aap.2017.38.4069
- By:
- Publication type:
- Article
A 6-month safety and efficacy study of fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers in persistent asthma.
- Published in:
- Allergy & Asthma Proceedings, 2017, v. 38, n. 4, p. 264, doi. 10.2500/aap.2017.38.4061
- By:
- Publication type:
- Article
A randomized study of BI 671800, a CRTH2 antagonist, as add-on therapy in poorly controlled asthma.
- Published in:
- Allergy & Asthma Proceedings, 2017, v. 38, n. 2, p. 157, doi. 10.2500/aap.2017.38.4034
- By:
- Publication type:
- Article
The reservoir effect of topical steroids in vitiliginous skin: A cross-sectional study.
- Published in:
- Indian Journal of Dermatology, Venereology & Leprology, 2015, v. 81, n. 4, p. 370, doi. 10.4103/0378-6323.159933
- By:
- Publication type:
- Article
Synthesis of Difluoromethylthioesters from Aldehydes.
- Published in:
- Angewandte Chemie, 2018, v. 130, n. 6, p. 1679, doi. 10.1002/ange.201710731
- By:
- Publication type:
- Article
Efficacy of a wound-dressing biomaterial on prevention of postinflammatory hyperpigmentation after suction blister epidermal grafting in stable vitiligo patients: a controlled assessor-blinded clinical study with in vitro bioactivity investigation.
- Published in:
- Archives of Dermatological Research, 2020, v. 312, n. 9, p. 635, doi. 10.1007/s00403-020-02049-2
- By:
- Publication type:
- Article
"Out of the box" solution for skin problems due to glucose-monitoring technology in youth with type 1 diabetes: real-life experience with fluticasone spray.
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 4, p. 419, doi. 10.1007/s00592-019-01446-y
- By:
- Publication type:
- Article
The effect of medication cost transparency alerts on prescriber behavior.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Anti-inflammatory effects of the novel inhaled phosphodiesterase type 4 inhibitor CHF6001 on virus-inducible cytokines.
- Published in:
- Pharmacology Research & Perspectives, 2016, v. 4, n. 1, p. n/a, doi. 10.1002/prp2.202
- By:
- Publication type:
- Article
Quantitative comparison of dose–effect and time–course of fluticasone furoate and fluticasone propionate in adult and adolescent patients with persistent asthma: A systematic review and meta‐analysis.
- Published in:
- Respirology, 2022, v. 27, n. 3, p. 194, doi. 10.1111/resp.14203
- By:
- Publication type:
- Article
CORRIGENDUM.
- Published in:
- Respirology, 2020, v. 25, n. 10, p. 1103, doi. 10.1111/resp.13925
- Publication type:
- Article
Asthma prescribing: Where are we headed?
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Oral Presentation – Asthma.
- Published in:
- 2014
- Publication type:
- Abstract
1‐C2: Asthma 2.
- Published in:
- 2013
- Publication type:
- Abstract
OS14: COPD 1.
- Published in:
- 2013
- Publication type:
- Abstract
OS10: Asthma 2.
- Published in:
- 2013
- Publication type:
- Abstract
OS10: Asthma 2.
- Published in:
- Respirology, 2013, v. 18, p. 17, doi. 10.1111/resp.12183_10
- Publication type:
- Article
Fluticasone uptake across Calu-3 cells is mediated by salmeterol when deposited as a combination powder inhaler.
- Published in:
- Respirology, 2013, v. 18, n. 8, p. 1197, doi. 10.1111/resp.12146
- By:
- Publication type:
- Article
Treatment of the feline atopic syndrome – a systematic review.
- Published in:
- Veterinary Dermatology, 2021, v. 32, n. 1, p. 43, doi. 10.1111/vde.12933
- By:
- Publication type:
- Article
Vanadium exposure exacerbates allergic airway inflammation and remodeling through triggering reactive oxidative stress.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2022.1099509
- By:
- Publication type:
- Article
Targeting ETosis by miR-155 inhibition mitigates mixed granulocytic asthmatic lung inflammation.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.943554
- By:
- Publication type:
- Article
Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia – An Observational Real-World Clinical Study
- Published in:
- Patient Preference & Adherence, 2023, v. 17, p. 141, doi. 10.2147/PPA.S389875
- By:
- Publication type:
- Article
A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US.
- Published in:
- Journal of Asthma & Allergy, 2016, v. 9, p. 135, doi. 10.2147/JAA.S98172
- By:
- Publication type:
- Article
Bacterial regulation of macrophage bacterial recognition receptors in COPD are differentially modified by budesonide and fluticasone propionate.
- Published in:
- PLoS ONE, 2019, v. 14, n. 1, p. 1, doi. 10.1371/journal.pone.0207675
- By:
- Publication type:
- Article
Video education versus face-to-face education on inhaler technique for patients with well-controlled or partly-controlled asthma: A phase IV, open-label, non-inferiority, multicenter, randomized, controlled trial.
- Published in:
- PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0197358
- By:
- Publication type:
- Article
Nasal Steroids Use in the Prevention of Symptomatizing Adenoid Regrowth after Adenoidectomy.
- Published in:
- QJM: An International Journal of Medicine, 2021, v. 114, p. i111, doi. 10.1093/qjmed/hcab094.008
- By:
- Publication type:
- Article
Combined analysis of transcriptomic and genetic data for the identification of loci involved in glucocorticosteroid response in asthma.
- Published in:
- Allergy, 2021, v. 76, n. 4, p. 1238, doi. 10.1111/all.14552
- By:
- Publication type:
- Article
Batch-to-batch pharmacokinetic variability confounds current bioequivalence regulations: A dry powder inhaler randomized clinical trial.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 223, doi. 10.1002/cpt.373
- By:
- Publication type:
- Article
An efficacy and safety evaluation of montelukast + fluticasone propionate vs. fluticasone propionate in the treatment of cough variant asthma in children: a meta-analysis.
- Published in:
- BMC Pulmonary Medicine, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12890-023-02721-z
- By:
- Publication type:
- Article
Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Fluticasone Propionate with Azelastine Versus Standalone Fluticasone Propionate as Nasal Spray in Allergic Rhinitis: A Prospective Comparative Study in a Rural Population of Northern India.
- Published in:
- Indian Journal of Otolaryngology & Head & Neck Surgery, 2023, v. 75, n. 3, p. 2168, doi. 10.1007/s12070-023-03856-5
- By:
- Publication type:
- Article
Nasal Breathing Exercise and its Effect on Symptoms of Allergic Rhinitis.
- Published in:
- Indian Journal of Otolaryngology & Head & Neck Surgery, 2012, v. 64, n. 2, p. 172, doi. 10.1007/s12070-011-0243-5
- By:
- Publication type:
- Article
Microencapsulation of Fluticasone Propionate and Salmeterol Xinafoate in Modified Chitosan Microparticles for Release Optimization.
- Published in:
- Molecules, 2020, v. 25, n. 17, p. 3888, doi. 10.3390/molecules25173888
- By:
- Publication type:
- Article
Optinose Xhance approved by FDA as first medical therapy for CRS.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
TGIF for Optinose Xhance: PDUFA Date is 3-16-2024 for First Medical Therapy for CRS.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Tailoring Dry Microparticles for Pulmonary Drug Delivery: Ultrasonic Spray Freeze-Drying with Mannitol and Salbutamol Sulphate.
- Published in:
- Processes, 2023, v. 11, n. 11, p. 3096, doi. 10.3390/pr11113096
- By:
- Publication type:
- Article
An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel.
- Published in:
- NPJ Primary Care Respiratory Medicine, 2017, p. 1, doi. 10.1038/s41533-016-0001-y
- By:
- Publication type:
- Article
The effect of umeclidinium added to inhaled corticosteroid/long-acting β<sub>2</sub>-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study.
- Published in:
- NPJ Primary Care Respiratory Medicine, 2016, p. 16031, doi. 10.1038/npjpcrm.2016.31
- By:
- Publication type:
- Article
Comparative Study of Topical Treatment in Allergic Rhinitis Using Azelastine and Fluticasone in a Combination Verses Fluticasone Propionate Alone.
- Published in:
- Journal of Krishna Institute of Medical Sciences (JKIMSU), 2019, v. 8, n. 2, p. 21
- By:
- Publication type:
- Article
SIMULTANEOUS REVERSE PHASE-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (RP-HPLC) ESTIMATION OF AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE, AND PHENYL ETHYL ALCOHOL IN DYMISTA (MEDA) NASAL SPRAY.
- Published in:
- Rasayan Journal of Chemistry, 2023, v. 16, n. 1, p. 76, doi. 10.31788/RJC.2023.1616916
- By:
- Publication type:
- Article
Effect of Yupingfeng granule assisted fluticasone propionate nasal spray on patients with AR and its regulation on IL-5, ICAM-1 and ECP.
- Published in:
- Indian Journal of Chemical Technology, 2022, v. 29, n. 6, p. 776, doi. 10.56042/ijct.v29i6.67389
- By:
- Publication type:
- Article
Effects of Inhaled Corticosteroids on the Innate Immunological Response to Pseudomonas aeruginosa Infection in Patients with COPD.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 15, p. 8127, doi. 10.3390/ijms23158127
- By:
- Publication type:
- Article
Real-life experience with benralizumab during 6 months.
- Published in:
- 2020
- By:
- Publication type:
- journal article